Key result
Systemic chemotherapy remains associated with a poor overall prognosis in predominantly DLBCL cardiac lymphoma.
Population
10 cases with cardiac lymphoma
Design
Case_series
Authors
Loading...
Consider cardiac lymphoma in unexplained dyspnea or chest pain; leaves open need for prospective studies on optimized therapies.
Observational (n=10)
No
Cardiac lymphoma is a rare condition that frequently presents with heart failure and arrhythmias and has a poor prognosis despite chemotherapy.
Li et al. (2017) conducted an observational in Cardiac lymphoma (n=10). Chemotherapy with or without radiotherapy was evaluated on Therapeutic outcomes and prognosis (Response rate, PFS, OS). Cardiac lymphoma is a rare condition predominantly of the DLBCL subtype that presents mainly with dyspnea and chest pain, and despite systemic chemotherapy, overall prognosis remains poor.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: